Following skeletal muscle injury, muscle stem cells (satellite cells) are activated, proliferate, and differentiate to form myofibers. We show that mRNA-decay protein AUF1 regulates satellite cell function through targeted degradation of specific mRNAs containing 3 0 AU-rich elements (AREs). auf1 À/À mice undergo accelerated skeletal muscle wasting with age and impaired skeletal muscle repair following injury. Satellite cell mRNA analysis and regeneration studies demonstrate that auf1 À/À satellite cell self-renewal is impaired due to increased stability and overexpression of ARE-mRNAs, including cell-autonomous overexpression of matrix metalloprotease MMP9. Secreted MMP9 degrades the skeletal muscle matrix, preventing satellite-cell-mediated regeneration and return to quiescence. Blocking MMP9 activity in auf1 À/À mice restores skeletal muscle repair and maintenance of the satellite cell population. Control of ARE-mRNA decay by AUF1 represents a mechanism for adult stem cell regulation and is implicated in human skeletal muscle wasting diseases.
In Brief
Chenette et al. demonstrate that the mRNA binding protein AUF1 regulates muscle stem (satellite) cell function and fate through targeted degradation of mRNAs that determine satellite cell fate. auf1 À/À mice undergo accelerated skeletal muscle wasting with aging and impaired muscle repair following injury, and AUF1 mutations are implicated in some forms of muscular dystrophy.
INTRODUCTION
Many key regulatory mRNAs are controlled through post-transcriptional mechanisms; typically, the targeted destabilization of the mRNA, its selective translation, or both (Moore et al., 2014) . The regulated stability of mRNAs generally comprises those that must respond quickly in abundance to changing stimuli. In fact, almost half of the changes in physiologically rapid inducible gene expression occur at the level of mRNA stability (Cheadle et al., 2005) . Many physiologically potent proteins are encoded by short-lived mRNAs with half-lives of minutes, in which mRNA destabilization is conferred by AU-rich elements (AREs) in the 3 0 UTR. A common ARE motif consists of the sequence AUUUA, typically repeated multiple times in the 3 0 UTR, often contiguously (Moore et al., 2014) . The ARE is purely a cis-acting element that serves as a binding site for regulatory proteins known as AU-rich binding proteins (AUBPs), which bind the ARE with high affinity and control mRNA stability or translation. Several AUBPs have been studied to date, and all act by recruiting mRNA-decay, mRNA-stabilizing, or translation-arrest proteins (Gratacó s and Brewer, 2010) . AUBPs also have different and overlapping target ARE-mRNAs (Garneau et al., 2007; Kim et al., 2009) . ARE-mRNAs are thought to encode more than 5% of the protein-expressed genome (Gruber et al., 2011) .
AU-rich binding factor 1 (AUF1; also known as HNRNPD) binds certain ARE-mRNAs to promote their rapid degradation through association with trans-acting RNA binding proteins (Moore et al., 2014) . AUF1 primarily functions as an AREmRNA decay factor (Moore et al., 2014; von Roretz et al., 2011) . AUF1 consists of four related protein isoforms named for their molecular weights (p37, p40, p42, and p45), derived by differential exon splicing of a common pre-mRNA (Wagner et al., 1998) . While not fully understood, the different isoforms target ARE-mRNAs for decay and interact in a variety of homoand hetero-complexes (Moore et al., 2014) . AUF1 isoforms have also been implicated in transcriptional control of several genes based on their multimer formation and cellular distribution (Pont et al., 2012; Zucconi et al., 2010) , as AUF1 isoforms can shuttle between the nucleus and cytoplasm at different efficiencies (He and Schneider, 2006; Sarkar et al., 2003a Sarkar et al., , 2003b .
We previously developed an auf1 À/À (auf1 knockout; KO) mouse to better understand its physiological roles (Lu et al., 2006) . We report that auf1 À/À mice undergo accelerated skeletal muscle wasting as adults. Skeletal muscle maintenance and regeneration in adults requires activation and differentiation of normally quiescent satellite cells, a skeletal-muscle-specific stem cell population (Lipton and Schultz, 1979) . Satellite cells reside under the basal lamina, adjacent to myofibers, the bundles of muscle fibers that provide muscle mass and strength. Following muscle injury, satellite cells respond through rapid proliferation and differentiation, recapitulating the process of myogenesis (the formation of muscle tissue), including fusion, to form myofibers (Brack, 2014; G€ unther et al., 2013; Kudryashova et al., 2012; Lepper et al., 2009 ). Satellite cells must also self-renew and quiesce to prevent their depletion. Satellite cells, therefore, divide asymmetrically, enabling a small number of stem cells to return to quiescence, mediated partly through interaction with the satellite cell niche (Kuang et al., 2007) . The satellite cell niche is loosely defined as the intact laminin-basement membrane structure that provides poorly characterized extrinsic factors crucial for their maintenance (Bernet et al., 2014; Carlson and Conboy, 2007; Collins et al., 2005; Kuang et al., 2007; Montarras et al., 2005; Zammit et al., 2004) . Skeletal muscle regeneration is impaired in age-related diseases such as sarcopenia, which is marked by reduced muscle regenerative capacity with aging, partly due to a reduction in satellite cells (Bernet et al., 2014; Carlson and Conboy, 2007; Shefer et al., 2006) . Loss of the satellite cell population may result from a release of cell-cycle inhibition (Sousa-Victor et al., 2014) and/or loss of the niche (Gopinath and Rando, 2008) . These events are also common to certain adult late-onset myopathies, including limb girdle muscular dystrophy (LGMD).
LGMD is a heterogeneous family of diseases characterized clinically by adult-onset rapid loss of skeletal muscle in the pelvic, scapular, shoulder, and limb regions of the body (Brack, 2014; G€ unther et al., 2013; Kudryashova et al., 2012; Lepper et al., 2009) .
Therefore, we sought to elucidate the role of AUF1 in skeletal muscle maintenance with age. Here, we show that AUF1-mediated control of satellite cell ARE-mRNA stability is a key regulator (B) DEXA measurement of lean muscle mass normalized to total mass in young (3-5 months old), mid-range (6-8 months old), and old (9-12 months old) WT (black) and KO (gray) satellite cell selfrenewal leads to impaired muscle regeneration and satellite cell depletion and, ultimately, promotes late-onset myopathy.
RESULTS

auf1
À/À Mice Increasingly Lose Muscle Mass and Strength with Age A severe loss in skeletal muscle mass was apparent in auf1
skeletal muscle relative to wild-type (WT) littermates by 6 months of age, as evident in anatomical images ( Figure 1A ). The progressive loss of skeletal muscle mass in auf1 À/À mice was quantified by dual-energy X-ray absorptiometry (DEXA), which measures body composition, including skeletal muscle mass (Harada, 2013; Marinangeli and Kassis, 2013) . DEXA analysis showed a reduction in auf1 À/À mouse skeletal muscle mass of 50% by 6 months of age and 85% by 9 months ( Figure 1B) . Thus, there is a severe, progressive loss of skeletal muscle mass associated with age in auf1 À/À mice. Therefore, we determined whether the loss of muscle mass corresponds to a loss of muscle strength as well, using two traditional approaches. The inverted cage flip quantifies the amount of time a mouse can hold on to the bottom of a cage. This is a measure of both limb and pectoral strength. The grip strength test quantifies forelimb strength in countering an opposite pull. The age-related reduction in skeletal muscle mass corresponded to a 92% loss in whole-body skeletal muscle strength, measured by the inverted cage flip test ( Figure 1C ). The significant loss of limb muscle strength was independently validated by the grip strength test ( Figure S1 ). Histologically, young auf1 KO mice initially develop normal skeletal muscle, shown by laminin staining of tibialis anterior (TA) muscle fibers at 4 months of age, indistinguishable from WT animals ( Figure 1D ). At this time, laminin completely outlines rounded skeletal muscle fibers with virtually all peripheral myonuclei ( Figure 1E ), a key measure of normal muscle development (Wicklund and Kissel, 2014) . However, auf1 KO mice develop a drastic myopathy phenotype by 8 months of age, particularly showing signs of muscle wasting ( Figure 1D ). This is visually apparent in deficient and disrupted laminin staining indicative of a loss of muscle integrity, including skeletal muscle fibers that are incomplete with pronounced degradation. Notably, the 8-month-old auf1 KO phenotype includes a >5-fold increase in centrally located nuclei within muscle fibers ( Figure 1E ), indicative of ongoing satellite cell regeneration efforts and a phenotypic hallmark of myopathic disease (Wicklund and Kissel, 2014) .
AUF1 Shows Exclusive Expression in Activated Satellite
Cells within the Muscle Studies have shown that AUF1 is expressed at extremely low or negligible levels in skeletal muscle fibers (Lu and Schneider, 2004) (Figures 2A and 2B ). Therefore, we screened for AUF1 expression using immunofluorescence specifically in the quiescent and activated satellite cell populations in vivo following injury and in vitro on isolated skeletal muscle fibers. Quiescent satellite cells are identified by the expression of PAX7 and Syndecan-4 (Sdc4), while activated satellite cells additionally gain expression of myogenic regulatory factors (MRFs) such as MyoD (Cornelison and Wold, 1997; Seale and Rudnicki, 2000) . There was little or no detectable AUF1 expression in quiescent satellite cells prior to muscle injury. However, AUF1 was co-expressed in $25% of the activated PAX7 + satellite cells 7 days post-injury (Figures 2A and S2 ). In skeletal muscle, both uninjured and at 7 days post-injury, AUF1 expression was not observed in the skeletal muscle fibers (Figure 2A ). AUF1 is, therefore, specifically expressed in a subset of activated satellite cells.
To further validate restriction of AUF1 expression to activated satellite cells, skeletal muscle fibers were isolated, cultured, and screened for AUF1 co-expression with MyoD, an early time point MRF. The isolation of muscle fibers activates associated satellite cells that attempt to repair the sensed ''wound'' by differentiation. At 72 hr of culture, AUF1 was strongly co-expressed in >50% of the MyoD + satellite cells (Figures 2B and S2) . Notably, AUF1 distribution was found to be nuclear and cytoplasmic, indicative of increased cytoplasmic ARE-mRNA decay function. AUF1 has been shown to shuttle between the nucleus and the cytoplasm (the cytoplasm being where it promotes ARE-mRNA decay). At steady state, AUF1 is primarily nuclear, with export to the cytoplasm occurring as a result of specific mRNA association for decay (Moore et al., 2014; Sarkar et al., 2003a; Suzuki et al., 2005; Yoon et al., 2015; He and Schneider, 2006) . Collectively, these data demonstrate that AUF1 is only expressed in activated satellite cells in skeletal muscle and not in muscle fibers.
Independent confirmation of the AUF1 temporal expression profile was obtained using the murine myoblast C2C12 cell line. C2C12 cells can mimic the post-activated satellite cell state initiating at the progenitor myoblast level (Ho et al., 2015; Silva et al., 2015) . The three largest AUF1 isoforms (p40, p42, and p45) are expressed in the proliferating myoblast ( Figure S3 ) and significantly increased through the early stages of myoblast differentiation, similar to the differentiation of skeletal muscle satellite cells in the animal. The smallest isoform (p37) is minimally expressed in the fully differentiated myotubes ( Figure S3 ). differentiation, the TA muscle was injured by injection of BaCl 2 in WT and auf1 KO mice at 4 months of age. BaCl 2 causes rapid necrosis of the injected muscle. At this time point, as shown earlier, uninjured skeletal muscle from auf1 KO mice is morphologically normal ( Figure 1E ), and expression of AUF1 in the quiescent satellite cell population is almost undetectable ( Figures 2A and S4 ). Furthermore, there are no changes in the number of quiescent satellite cells present in the TA muscle of WT and auf1 KO mice at 4 months of age ( Figure 3C ). At 7 days post-injury, the TA muscle from auf1 KO mice is unable to undergo repair compared to that from WT animals. There is sparse laminin expression with very few identifiable myofibers, indicative of loss of muscle fiber integrity and disruption of the satellite cell niche (Figure 3A) . Evidence for loss of the satellite cell niche includes a >5-fold reduction in activated PAX7
+ satellite cells in the auf1 KO TA muscle relative to WT ( Figures 3A and 3C ). At 15 days post-injury, auf1 KO TA muscle continues to show little regeneration in comparison to the near-complete repair in WT mice. Laminin staining in the auf1 KO TA muscle indicates that significantly smaller and incomplete muscle fibers are formed (Figure 3A) , quantified by determining the size (minimum Feret's diameter) of muscle fibers ( Figure 3B ). There is also a significant depletion of the PAX7 + satellite cell population in the auf1 KO TA muscle at this time ( Figure 3A) , quantified by scoring the number of PAX7 + cells per square millimeter ( Figure 3C ). AUF1 expression is, therefore, crucial for the maintenance and re-establishment of both the satellite cell niche and the PAX7 + stem cell population.
Since the primary function of AUF1 is to target ARE-mRNAs for rapid decay, we sought to identify mRNAs with altered abundance in sorted satellite cells from auf1 KO mice compared to WT. We conducted genome-wide, satellite-cell-specific RNA sequencing (RNA-seq) mRNA expression analysis. Satellite cells were isolated from auf1 WT and auf1 À/À KO mouse whole hindlimb skeletal muscle from 4-to 6-month-old animals by fluorescence-activated cell sorting (FACS), gating on cells positive for satellite cell marker Sdc4 and negative for endothelial cell markers. Ninety-one mRNAs were altered in abundance in auf1 KO, compared to WT, satellite cells, with $75% ($70 mRNAs) showing >2-fold increased abundance. Of these, 34/70, or almost half, were mRNAs containing 3 0 UTRs with putative AUF1/AUBPbinding AREs based on the ARE-motif AUUUA, typically with at least two contiguous AUUUA sequences required for AUF1 binding (Moore et al., 2014) . Additionally, the majority of the ARE-mRNAs were increased in abundance, supporting the role of AUF1 in promoting ARE-mRNA decay in the stem cell population (Figure 4A ; Table S1 ). Interestingly, 18 mRNAs were increased in abundance only in auf1 KO satellite cells and were not detectable in the WT, of which 8 contain 3 0 UTR multiple AREs, including established targets of AUF1 such as IL17 (Han et al., 2014) . Other established ARE-mRNA targets of AUF1 increased in abundance in auf1 KO satellite cells, compared to WT, and include IL10 (Sarkar et al., 2008) , MMP9 (Liu et al., 2006) , GBP1, SAMSN1 (Sarkar et al., 2011) , and IL1b (Pont et al., 2012) .
Next, we performed in silico analysis to identify favorable AUF1-regulated ARE-mRNAs, focusing on mRNAs upregulated in the auf1 KO satellite cells consistent with the primary function of AUF1 in mediating ARE-mRNA decay. mRNAs with at least one canonical ARE motif (AUUUA) in the 3 0 UTR were identified using ARESite (Table S1 , identified with an asterisk). These mRNAs were further prioritized as AUF1-preferred targets based on established AUF1 preference for at least two ARE pentamers, often adjacent (Gratacó s and Brewer, 2010) (Table S1 , identified with two asterisks). The prioritized gene list was subjected to ingenuity pathway analysis (IPA) to determine functional clusters. IPA assigns gene lists to experimentally authenticated biochemical and molecular networks. IPA revealed that upregulated mRNAs were enriched for functions including cell movement, cell-to-cell signaling, cell maintenance, and cell growth ( Figure 4B ). These pathways provide crucial signaling for the proper activation, differentiation, and self-renewal of stem cells in adult tissue. Notably, the upregulated MMP9 transcript was identified in most of these cellular function pathways. We characterized the importance of the genes identified by IPA by established function in skeletal muscle regeneration. Four ARE-mRNAs were identified (Table S2) , with two (IL17, MMP9) having been previously shown to bind AUF1 in other cell types (Han et al., 2014) .
MMP9 has a central importance in muscle regeneration and wound repair (Webster et al., 2016; Gu et al., 2005; Hindi et al., 2013; Murase and McKay, 2012) and was found in most of the relevant pathways analyses that we conducted. MMP9 is a matrix metallopeptidase that degrades extracellular matrix (ECM) proteins, including skeletal muscle laminin, a component of the satellite cell niche (Gu et al., 2005; Hindi et al., 2013; Murase and McKay, 2012) . While controlled remodeling of the ECM is required for skeletal muscle regeneration, excessive and/or continuous post-wounding MMP9 activity would be predicted to deregulate satellite cell function and impair stem-cell-regenerative capacity through chronic degradation of the surrounding matrix (Webster et al., 2016; Shiba et al., 2015) . Accordingly, inhibition of MMP9 has been shown to improve skeletal muscle repair in certain models of muscular dystrophy (Hindi et al., 2013; Li et al., 2009; Shiba et al., 2015) . Moreover, the extensive pathological effects of muscle wounding in auf1 KO mice are consistent with the predicted phenotype of increased MMP activity.
Importantly, the source of MMP9 expression during muscle wound repair and its pathological relevance when overexpressed have not been studied. Therefore, we first confirmed that changes in MMP9 and other mRNAs identified by genome-wide satellite cell RNA-seq analysis are, in fact, satellite cell autonomous. To do so, we conducted a genome-wide gene expression analysis of mRNAs in the WT and auf1 KO mouse skeletal muscle fibers taken from 4-to 6-month-old animals (Figure S5) . MMP9 mRNA was undetectable in both WT and KO skeletal muscle fibers, indicating that MMP9 expression is solely satellite cell autonomous and the source of MMP9 overexpression in auf1 KO mice.
Verification that AUF1 promotes MMP9 mRNA degradation was obtained in C2C12 myoblast cells, since it is not feasible to study mRNA decay rates in the animal satellite cell population. Silencing of AUF1 by two different small interfering RNAs (siRNAs) ($80%) increased MMP9 mRNA levels by $4-fold ( Figure 4C ), consistent with that identified in the RNAseq data from satellite cells. MMP9 mRNA relative half-life, determined by the addition of actinomycin D to block transcription and qRT-PCR quantitation, was increased from 1 hr in vehicle-treated controls to 4.5 hr in C2C12 cells treated with small interfering (si)AUF1 ($80% silenced) ( Figure 4D ). To confirm that MMP9 mRNA destabilization is the result of AUF1 action on the ARE repeats in the 3 0 UTR, the longest contiguous ARE-rich region ($200 bp) was cloned into the 3 0 UTR of a luciferase reporter (pzeo-luc). The MMP9-3 0 -Luc reporter or its control (Empty-3 0 -Luc) was transfected into C2C12 cells with either non-silencing or siAUF1 treatment. The control mRNA had a relatively stable half-life of 112 min, which was significantly reduced to 28 min by the insertion of the MMP9 3 0 UTR ARE fragment (MMP9-3 0 -Luc) ( Figure S6A ). siAUF1 treatment, which partially silenced AUF1 by 50%-70%, partially rescued MMP9-3 0 -Luc mRNA stability (81 min). These data confirm that AUF1 promotes the decay of the MMP9 mRNA through the AU-rich 3 0 UTR ( Figure S6A ). Further validating these results, cells treated with siAUF1 showed significantly increased luciferase activity, validating the role of AUF1 in promoting MMP9 instability ( Figure S6B ).
Additionally, MMP9 mRNA was found strongly bound to immunoprecipitated AUF1 from WT C2C12 cells ( Figures 4E and S7A) . A suspected AUF1 target mRNA in certain cell types, Integrinb-1 (ITGB1), which was not altered in the satellite cell RNA-seq data, was used as a control. ITGB1 did not associate with AUF1 in the C2C12 cells, validating the interaction with MMP9 ( Figure 4E ). Moreover, silencing of AUF1 in C2C12 cells strongly increased secreted MMP9 protein levels ( Figures S7B and S7C ).
MMP9 Inhibition Rescues Depletion of auf1
À/À Satellite
Cells following Injury
We determined in live animals, in vivo, whether loss of AUF1-targeted decay of the MMP9 ARE-mRNA is, in large part, responsible for the post-injury muscle regeneration defect, validating that this phenotype is caused by overexpression from auf1 KO satellite cells. We used live animal imaging to visualize MMP9 activity in auf1 WT and auf1 À/À KO TA skeletal muscle at 24 hr postinjury in 4-month-old mice. This corresponds to a time point at which satellite cells are activated in the absence of an immune infiltrate (Dumont et al., 2015) . Mice received an intraperitoneal (i.p.) injection (in the abdominal cavity) with an optically silent collagen matrix analog designed for selective MMP9 cleavage starting 24 hr prior to injury. Once cleaved, the matrix releases a fluorophore localized to the site of MMP9 activity. MMP9 activity at the site of repeated i.p. needle injections was expected. Following BaCl 2 TA muscle injury, MMP9 was strongly (>3-fold) more active in the injured TA skeletal muscle of auf1 KO mice compared to WT mice ( Figure 5A ). No MMP9 activity was evident in the uninjured right hindlimb control in both the WT and auf1 KO mice ( Figure 5A ). Surgical excision of the injured TA muscle from WT and auf1 KO mice, followed by bioluminescence imaging ( Figures 5B and 5C ), confirmed that there is an average 3-fold increase in continuous MMP9 activity in auf1 KO mice compared to WT mice. These data indicate that activated auf1 KO satellite cells secrete continuous and increased levels of active MMP9 following muscle injury, which is likely exacerbated as the satellite cell population expands. Therefore, we sought to determine whether the increased expression and activity of MMP9 are responsible for the auf1 KO injury phenotype observed, particularly, the severe loss of laminin and depletion of the satellite cell population. Chronically increased MMP9 activity may promote excessive ECM damage and subsequent disruption of the satellite cell niche, ultimately inhibiting satellite cell return to PAX7 + quiescence by interrupting crucial cell-niche crosstalk. To test this, a MMP9 small-molecule inhibitor, SB-3CT (Jia et al., 2014; Sassoli et al., 2014) , was administered through i.p. injection to auf1 KO mice in conjunction with BaCl 2 -mediated TA injury. SB-3CT blocks MMP9 activity through an irreversible covalent interaction (Jia et al., 2014; Sassoli et al., 2014) . Mice were treated with 10 mg/kg SB-3CT daily, starting 24 hr prior to injury, in combination with MMP9-specific collagen matrix injections (Cai et al., 2015) . auf1 KO mice treated with SB-3CT showed near-complete extinction of MMP9 activity at the site of i.p. injection and significantly reduced MMP9 activity in the injured TA muscle ( Figure 6A ). Bioluminescence analysis demonstrated a >5-fold reduction in MMP9 activity in SB-3CT-treated mice post-injury ( Figure 6B ). The scale used to quantitate fluorescence is shown in Figure 5 .
The reduction in MMP9 activity by SB-3CT treatment in injured auf1 KO mice resulted in the restoration of muscle wound repair. Laminin expression was strongly increased, and near-normal muscle fibers were evident in injured, SB-3CT-treated auf1 KO animals, consistent with repair of the satellite cell niche (Figure 6C) . Furthermore, the PAX7 + satellite cell population underwent significant increased expansion 7 days post-injury only in MMP9-inhibited (SB-3CT-treated) auf1 KO mice ( Figure 6C ). Specifically, an $4-fold increase was found in the PAX7
+ satellite cell population with SB-3CT treatment following injury (Figure 6D ). These data demonstrate that the severe myopathic pathology of auf1 KO mice following skeletal muscle injury is due to the loss of AUF1-targeted ARE-mRNA decay, resulting in increased and constitutive muscle tissue remodeling through elevated MMP9 activity and subsequent loss of stem cell maintenance. These findings further identify the source of late-onset myopathy observed in aging auf1 KO mice: the accelerated depletion of the satellite cell population and increased degradation of laminin due to loss of AUF1-mediated regulation of AREmRNA decay. In both phenotypes, the source of increased MMP9 is the activated auf1 KO satellite cell, itself causing the loss of self-renewal, making auf1 À/À satellite cells act in a selfsabotaging manner.
DISCUSSION
The targeted decay of ARE-mRNAs by AUBPs has emerged as a major regulator of many complex physiological pathways and a source of disease when it goes awry (Moore et al., 2014) . AUBPs have multiple poorly understood roles in orchestrating the process of myogenesis, whether during development or regeneration following wound repair. Studies indicate that the complex and temporally ordered process of muscle regeneration, including the regulation, differentiation, and restoration of satellite cells in this process, involves a tightly regulated AUBP network (Dormoy-Raclet et al., 2013; Figueroa et al., 2003; Hausburg et al., 2015; Legnini et al., 2014; Panda et al., 2014; Singh et al., 2014) . The individual AUBP molecular activities and coordination of their respective functions are very poorly understood, particularly in the context of stem-cell-mediated regeneration. Here, we focused on the role of AUF1 in satellite-cell-mediated skeletal muscle repair, demonstrating that, in the absence of functional AUF1, certain ARE-mRNAs in satellite cells are increased in abundance, disrupting satellite cell differentiation and self-renewal following wounding. The elevated expression of active MMP9, encoded by an AUF1-targeted ARE-mRNA, was found to uncontrollably degrade the surrounding skeletal muscle ECM, including laminin and the satellite cell niche, generating a myopathic phenotype similar to that of a variety of lateonset human myopathic diseases. The finding that auf1 À/À mice show accelerated skeletal muscle wasting with aging is likely a result of increased satellite-cellsecreted MMP9 activity following accumulative minor wounds over time. Our findings demonstrate that continuous MMP9 activity damages the laminin and ECM structures, disrupting the quiescent satellite cell niche. This results in a relentless cycle of destructive degradation and repair established by an MMP9-driven muscle wounding response, which prematurely activates and depletes yet more satellite cells. Activated satellite cells then fuse to existing myofibers, as indicated by the increase in centrally located nuclei in 8-month-old auf1 À/À mice. Consequently, the loss of functional AUF1, specifically in satellite cells, leads to a late-onset myopathy, with no phenotype present at a young age. The chronic and increased expression of MMP9 in the absence of AUF1-mediated ARE-mRNA decay is, therefore, clearly a major driver of age-related and post-injury myopathy. Importantly, the disruption of the satellite cell niche by increased and unregulated MMP activity in auf1 À/À mice leads to the partial depletion of the quiescent PAX7 + satellite cell population, culminating in the development of a late-onset myopathy observed in aging and following muscle injury.
Although additional ARE-mRNAs other than MMP9 identified in the satellite cell RNA-seq analysis likely contribute to the determination of satellite cell fate and the regulation of skeletal muscle integrity and regeneration, it is clear that AUF1 regulation of MMP9 ARE-mRNA decay defines a primary controlling step. In this regard, the ability to not only restore laminin expression-and, therefore, muscle regeneration-but also increase the expansion of auf1 À/À PAX7 + satellite cells by treatment with the MMP9 inhibitor SB-3CT underscores the important function of AUF1-mediated decay of a single ARE-mRNA (MMP9). This further validates the importance of AUF1-regulated ARE-mRNA decay in the activation and self-renewal of satellite cells, mediated through their interaction with the niche. Future studies will be directed to understanding the role of AUF1 in later stages of muscle regeneration, including expansion, differentiation, and fusion of the satellite cell. Accordingly, MEF2C, a latestage MRF and AUF1 mRNA target (Panda et al., 2014) , was not identified in our RNA-seq analysis, presumably due to the time point in regeneration at which auf1 À/À satellite cells were selected and sorted for this study. The chronic and increased expression of MMP9 in the absence of AUF1-mediated ARE-mRNA decay is, therefore, clearly a major driver of age-related and post-injury myopathy. Importantly, the disruption of the satellite cell niche by increased MMP9 activity in auf1 À/À mice leads to the partial depletion of the quiescent PAX7 + satellite cell population, culminating in the development of a late-onset myopathy observed in aging and following muscle injury. This work addresses the importance of post-transcriptional control in the coordinated process of tissue regeneration. Studies could prove extremely beneficial to further understanding the multiple roles of the different AUBPs in coordinating myogenesis and muscle regeneration. Clearly, AUF1 functions at different temporal points in the process of myogenesis, shown by work in C2C12 cells (Panda et al., 2014) and here. HuR, another AUBP that often opposes AUF1 action and stabilizes ARE-mRNAs (Figueroa et al., 2003) , increases in satellite cells in the very early stages of activation (Legnini et al., 2014) , at a time before the rise in AUF1 expression. HuR promotes the stability of certain MRFs, such as myogenin and MyoD (Figueroa et al., 2003) . HuR was also recently shown to stabilize the noncoding RNA linc-MD1, with high expression in the earliest stages of myogenesis (Legnini et al., 2014) , and the mRNA hmgb1 following injury. HMGB1 promotes a motility program involved as an early activator of the skeletal muscle repair response (Dormoy-Raclet et al., 2013 ). Yet another AUBP, TTP, which is also an ARE-mRNA-decay mediator, is highly expressed in only quiescent satellite cells, when AUF1 is not expressed. Furthermore, TTP shows immediate inactivation following injury when AUF1 expression increases dramatically (Hausburg et al., 2015) . In the quiescent satellite cell, TTP mediates the rapid decay of the MyoD mRNA, preventing expansion of the satellite cell population. Previous studies have shown that AUF1 and TTP tend to show mutually exclusive expression or activity (Moore et al., 2014) , consistent with these findings and with our data that AUF1 is only expressed following satellite cell activation.
Reported data led to the possibility that the loss or mutation of AUF1 was related to the development of LGMD, a late-onset human myopathy. Multiple family cohorts with LGMD type 1G have a mutation in the 4q21 locus, which contains the auf1 gene, and one family was shown to have a mutation in HNRNPDL, a poorly described AUF1 homolog (Starling et al., 2004; Vieira et al., 2014) . The age of onset for LGMD type 1G ranged from 30 to 47 years, with no childhood history of myopathy (Starling et al., 2004; Vieira et al., 2014) . As clinically described, LGMD shows a similar relative age of onset and histological representation as identified in the auf1 À/À mouse.
In summary, our work identifies a myopathy of true satellitecell origin in an animal model and places the AUBP mRNA-decay protein AUF1 as a key regulator of adult stem cell fate. These findings have important clinical implications. While healthy skeletal muscle can develop in the absence of functional AUF1, the satellite-cell population is clearly altered and, once activated, is quickly depleted. Activated auf1 À/À satellite cells secrete elevated levels of MMP9 that continuously break down the ECM and niche, causing premature satellite cell activation, satellite cell depletion, and subsequent development of myopathy with age. Consequently, a combination of MMP9 inhibition and potential AUF1-mediated satellite cell therapy may have a role in regenerative medicine for chronic and acute adult myopathies.
EXPERIMENTAL PROCEDURES Animal Studies
All animal studies were approved by the New York University (NYU) School of Medicine Institutional Animal Care and Use Committee protocol #140414-01 and conducted in accordance with IACUC guidelines.
DEXA
The Lunar Pixi DEXA was used to record lean tissue muscle mass as per manufacturer's recommendations. Male and female mice from 3 to 12 months of age were weighed for total body mass and scanned for lean body mass. Mice were divided into the following age groups: 3-5, 6-8, and 9-12 months. A ratio of lean body mass to total body mass was used for analysis. Five mice per genotype per age group were analyzed in triplicate, and then means and SDs were calculated. Data were analyzed with an unpaired t test. (Harada, 2013; Marinangeli and Kassis, 2013) .
Cage Flip
Male and female mice were placed on a grid for 30 s to acclimate before being inverted for up to 60 s at a height of 3 feet. The time until mice let go of the grid was recorded. Mice were divided into the following age groups: 3-5, 6-8, and 9-12 months. Five mice per genotype per age group were tested in triplicate, and then means and SDs were calculated. Data were analyzed with an unpaired t test.
Strength Grip
Male and female mice 6 months of age were tested as per manufacturer's recommendations (Bioseb). In brief, mice were handled by their tails and allowed to grab a grid attached to a force monitor with their upper limbs. Mice were pulled off the grid by their tail, and a measurement of upper limb strength was recorded. Five mice per genotype were tested in triplicate, and then means and SDs were calculated. Data were analyzed with an unpaired t test (Ke et al., 2015; van Norren et al., 2015) .
Immunofluorescence
Male and female mice 4-8 months of age (designated by experiment) had their TA muscles removed and frozen in OCT (optimum cutting temperature) compound (Tissue-Tek). Samples were post-fixed in 4% paraformaldehyde and blocked in 3% BSA in Tris-buffered saline (TBS). Primary antibodies were incubated at 4 C overnight. Alexa Fluor donkey 488, 555, and 647 secondary antibodies were used at 1:500 and incubated for 1 hr at room temperature. Slides were sealed with Vectashield with DAPI. The following antibody dilutions were used: rat antibody to laminin (Sigma, L0663, 1:250), mouse antibody to PAX7 (Developmental Studies Hybridoma Bank [DSHB], 1:1,000; PAX7 was deposited to the DSHB by Atsushi Kawakami), goat antibody to HNRNPD (Santa Cruz Biotechnology, SC-22368, 1:250), and rabbit antibody to MyoD (Santa Cruz Biotechnology, SC-760, 1:1,000).
Microscopy, Image Processing, and Analysis
Images were acquired using a Zeiss LSM 700 confocal microscope, primarily with the 203 lens. Images were processed and scored using ImageJ64. If needed, color balance was adjusted linearly for the entire image and all images in experimental sets.
BaCl 2 Hindlimb Injury
Male and female mice at 4 months of age were injected with 50 ml filtered 1.2% BaCl 2 in saline directly in the left TA muscle. The right TA muscle remained uninjured as a control. Mice were monitored and sacrificed by protocol at 7 and 15 days post-injection. Injured and uninjured TA muscles were surgically removed and frozen in OCT compound (Tissue-Tek) post-sacrifice. Three mice per genotype per time point were studied (Bernet et al., 2014; Cornelison et al., 2001 ).
Myofiber Preparation
Myofibers were harvested from WT and KO mice at 4 months of age. In brief, muscles beneath the TA muscle, including the extensor digitorum longus (EDL) and soleus, were dissected from the hindlimb and digested in 1.5 U/ml type 1 collagenase (Worthington) for 1.5 hr in a 37 C water bath. Myofibers were cultured for 72 hr in F12 media (Corning) supplemented with 15% horse serum (GIBCO), 1% penicillin-streptomycin (Life Technologies), and 2.5 mg/ml fibroblast growth factor (FGF; Sigma) at 37 C in a 5% CO 2 tissue culture incubator (Tanaka et al., 2009 ).
C2C12 Cell Culture C2C12 cells were maintained in DMEM (Corning), 20% fetal bovine serum (FBS; GIBCO), and 1% penicillin-streptomycin (Life Technologies). To differentiate cells, media were switched to DMEM (Corning), 2% horse serum (GIBCO), and 1% penicillin-streptomycin (Life Technologies) (Panda et al., 2014) .
FACS
Whole hindlimb skeletal muscle from male and female mice ages 4-6 months old was digested in type 1 collagenase (Worthington) and sorted for the Sdc4 + cd45
À population using a Beckman Coulter MoFlo XDP cell sorter. Lineage markers were excited by a Sapphire 488-nm laser (Coherent) and collected via a 530/40 band-pass filter. Sdc4 (conjugated to Qdot 800 using the SiteClick antibody conjugation kit) was also excited by a Sapphire 488-nm laser (Coherent) and collected via a 740 long-pass filter. DAPI was used to select for live/intact cells and was excited by a JDSU Xcyte 355-nm laser and collected via a 450/65 band-pass filter. Events were run through a 70-mm cyto-nozzle at approximately 10,000 events per second.
RNA-Seq and Analysis
RNA was extracted from FACS-sorted satellite cells using TRIzol (Thermo Fisher Scientific) and purified using the RNeasy Mini Kit (QIAGEN) as per manufacturer's instructions. Whole hindlimb skeletal muscle of male and female mice ages 4-6 months old was processed. Three mice were analyzed per genotype. RNA-seq was completed through the NYU School of Medicine Genome Technology Core, using the Illumina Hi-Seq 2500 Single Read, and analyzed through the NYU-CTSI (Clinical and Translational Science Institute) Bioinformatics Core.
Affymetrix Genome-wide mRNA Analysis RNA was extracted from whole hindlimb skeletal muscle with TRIzol (Thermo Fisher Scientific) and purified using the RNeasy Mini Kit (QIAGEN) as per manufacturer's instructions. Whole hindlimb skeletal muscle of male and female mice 4-6 months old was processed. Five mice were analyzed per genotype. Affymetrix GeneChip Mouse Genome 430 2.0 Array chips were used. Affymetrix chips were processed by the NYU School of Medicine Genome Technology Core and analyzed through the NYU School of Medicine Bioinformatics Core.
In Vitro AUF1 Silencing AUF1 was transiently silenced in vitro using 50 mM Ambion siRNA (s62815, s201078) and Life Technology Lipofectamine 2000 for 48 hr. For extended studies, cells were treated with siRNA every 72 hr as needed.
MMP9 ELISA
Tissue culture media were collected and tested using the Molecular Probes EnzChek Gelatinase/Collagenase Assay Kit, as per manufacturer's instructions. Experiments were analyzed in triplicate, and then means and SDs were calculated. Data were analyzed by unpaired t test.
In Vivo MMP9 Activity WT and KO male and female mice 4 months of age were given an i.p. injection with PerkinElmer MMPSense 750 solution 24 hr prior to injury and the time of BaCl 2 injection, 24 hr prior to imaging. Animals were imaged using IVIS L-III through the NYU School of Medicine Small Animal Imaging Core. Three mice per genotype were analyzed, and then means and SDs were calculated. Data were analyzed with an unpaired t test.
SB-3CT Treatment KO male and female mice 4 months of age were given an i.p. injection with 25 mg/kg SB-3CT (Sigma-Aldrich) every 24 hr, starting 24 hr prior to BaCl 2 injury with MMPSense injection. Three mice per treatment were analyzed, and then means and SDs were calculated. Data were analyzed with an unpaired t test.
Statistical Analysis
Unpaired t test or two-way ANOVA was used when applicable to determine significance. Data were analyzed using Prism 6.0f. Significant values are considered as p < 0.05, p < 0.005, and p < 0.0005.
ACCESSION NUMBERS
The accession number for the gene expression data, including all RNA-seq data, reported in this paper is GEO: GSE83555. 
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